.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Healthtrust
QuintilesIMS
Baxter
Julphar
Covington
UBS
US Army
McKesson
Moodys

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020316

« Back to Dashboard
NDA 020316 describes OXILAN-350, which is a drug marketed by Guerbet and is included in one NDA. Additional details are available on the OXILAN-350 profile page.

The generic ingredient in OXILAN-350 is ioxilan. There is one drug master file entry for this compound. Additional details are available on the ioxilan profile page.

Summary for 020316

Tradename:
2
Applicant:
1
Ingredient:
1
Patents:0

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength62%
Approval Date:Dec 21, 1995TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength73%
Approval Date:Dec 21, 1995TE:RLD:No

Expired Orange Book Patents for NDA: 020316

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Guerbet
OXILAN-300
ioxilan
INJECTABLE;INJECTION020316-001Dec 21, 1995► Subscribe► Subscribe
Guerbet
OXILAN-350
ioxilan
INJECTABLE;INJECTION020316-002Dec 21, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
US Army
Farmers Insurance
QuintilesIMS
Queensland Health
Accenture
Daiichi Sankyo
Colorcon
Healthtrust
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot